Does CETUXIMAB Cause Device occlusion? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Device occlusion have been filed in association with CETUXIMAB (ERBITUX). This represents 0.1% of all adverse event reports for CETUXIMAB.
16
Reports of Device occlusion with CETUXIMAB
0.1%
of all CETUXIMAB reports
2
Deaths
11
Hospitalizations
How Dangerous Is Device occlusion From CETUXIMAB?
Of the 16 reports, 2 (12.5%) resulted in death, 11 (68.8%) required hospitalization, and 1 (6.3%) were considered life-threatening.
Is Device occlusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CETUXIMAB. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does CETUXIMAB Cause?
Off label use (1,549)
Rash (883)
Diarrhoea (874)
Neutropenia (744)
Nausea (663)
Malignant neoplasm progression (662)
Dyspnoea (542)
Decreased appetite (541)
Vomiting (533)
Death (518)
What Other Drugs Cause Device occlusion?
PEGFILGRASTIM (3,239)
CARBIDOPA\LEVODOPA (1,464)
SOMATROPIN (823)
LEUPROLIDE (786)
EPOPROSTENOL (580)
TREPROSTINIL (458)
ALBUTEROL (431)
MEDROXYPROGESTERONE (284)
BACLOFEN (254)
LEVODOPA (224)
Which CETUXIMAB Alternatives Have Lower Device occlusion Risk?
CETUXIMAB vs CETYLPYRIDINIUM
CETUXIMAB vs CEVIMELINE
CETUXIMAB vs CHAMPIX
CETUXIMAB vs CHANTIX
CETUXIMAB vs CHENODIOL